Considering only events within various age groups, the ICERs indicated that SGLT2is were not cost-effective for people aged 1039 years or 4059 years for any intervention (although the ICER for SGLT2is in the secondary prevention population was 29,420), while SGLT2is were cost-effective among people aged 6079 years (ICERs of 28,002 and 328 in the primary prevention and secondary prevention populations, respectively) and 80 years, but GLP-1 RAs were not
By addressing diet, exercise, emotional well-being, and medical factors , Valencia Medical Center helps patients achieve long-term success
You have chronic medical conditions that make nutrition, activity, or follow-up more complicated
According to IQVIA, about 83% of the compounded GLP-1 market came through non-traditional channels, with patients turning to telehealth platforms and cash-pay compounders when brand-name access disappeared
BPC-157, a peptide derived from a naturally occurring protein in the human stomach, has been gaining attention for its remarkable therapeutic potential
